13 November 2018 -
The US Wound Dressing Market size is
expected to reach USD 4.25 billion by 2024. Growing aging population and cases
of diabetes and obesity are the major factors driving the market. Furthermore,
increasing incidence of pressure ulcers in bedridden, wheelchair-bound, and/or
physically impaired patients is expected to fuel the demand for wound care over
the forecast period. For instance, annually, 2.5 million individuals suffer
from pressure ulcer in U.S. and around USD 9.1 billion to USD 11.6 billion are
spent for its treatment.
Moreover,
growing cases of surgical procedures due to high incidence of wound infections
and diabetic foot are expected to boost the demand for wound dressing. This has
also increased the preference for advanced wound care products over simple
dressing. Advanced dressing offers rapid healing, reasonable cost, with minimal
inconvenience to the patient. However, owing to the demand for low cost
dressing, traditional methods are being used to some extent. This may have a
negative impact on the market development over the forecast period.
However,
availability of various insurance schemes in U.S. for affordable medical care
over long term, coupled with rise in consumer disposable income, is encouraging
people to opt for advanced healthcare. This is anticipated to contribute to
market expansion over the years to come.
The
advanced dressing technique is the fastest-growing segment expanding at a CAGR
of 4.4% over the forecast period. It also held the dominant market share of USD
1.8 billion in 2017. It is expected to reach USD 2.6 billion by 2024. Advanced
dressings includes moist, antimicrobial, and active dressings. Factors such as
rapid healing and minimal patient inconvenience are anticipated impel this
growth over the forecast period.
Chronic and
non-healing wounds are best treated with advanced wound dressing products.
Limitations of traditional wound care have propelled the growth of the segment.
Advanced moist wound care is recommended for chronic wounds like pressure and
diabetic ulcers, burn injuries, and other slow-healing wounds. Advanced foam
technique is essential to prevent and heal the exudation of burn injuries. All
these factors are projected to propel the growth of the U.S. wound dressing
market during the forecast period.
Advanced
alginate dressing is recommended in highly exuding wounds, as it forms a gel
around the wound bed and helps in keeping them dry and clean. Advanced alginate
dressing have gel-forming ability and they also help reduce the pain. As a
result, they are widely used for the treatment for bleeding wounds. Advanced
films provide healing to semi-dry and dry wounds. Advanced hydrocolloid
dressing helps protect the wound internally, as well as externally. Increasing
number of surgeries is expected to fuel the growth of hydrogel dressings. All
these factors are expected to propel the growth of the wound dressing market over
the forecast period.
Antimicrobial
dressings are easy to use, accessible without prescription, and less risk of
resistant. Silver and non-silver are the two types of this dressings. Silver
shows broad spectrum antibacterial activity and minimal toxicity towards host
cells. The non-sliver wound dressing may have single or combination of various
ingredients, such as iodine, chlorhexidine, Polyhexamethylbuguanide (PHMB),
honey, acetic acid, and potassium permanganate. This type of dressing is used
for faster healing process and for reducing the pain. Active wound dressings
are administered for the repair and healing through bioactive and
skin-substitute compounds. They are highly beneficial in healing chronic moist
wounds.
Hexa
Research has segmented the U.S. wound dressing market report based on product:-
Segmentation
by Product Type, 2013 - 2024
• Traditional
• Advanced
• Moist
• Foam
• Alginate
• Films
• Hydrocolloids
• Hydrogel
• Antimicrobial
• Silver
• Non-silver
• Active
• Biomaterials
• Skin-substitute
• Traditional
• Advanced
• Moist
• Foam
• Alginate
• Films
• Hydrocolloids
• Hydrogel
• Antimicrobial
• Silver
• Non-silver
• Active
• Biomaterials
• Skin-substitute
Key Players
Analyzed:
• 3M Healthcare
• Coloplast
• Medline Industries
• HARTMANN.
• BSN Medical
• Medtronic Plc
• Smith & Nephew
• ConvaTec
• Derma Sciences
• Systagenix
• 3M Healthcare
• Coloplast
• Medline Industries
• HARTMANN.
• BSN Medical
• Medtronic Plc
• Smith & Nephew
• ConvaTec
• Derma Sciences
• Systagenix
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry
No comments:
Post a Comment